PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsHuman immunoglobulin g
Baygam, gamastan s/d, Kiovig(human immunoglobulin g)
Human immunoglobulin g is an unknown pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Asceniv, Baygam, gamastan s/d, Bivigam, Cutaquig, Flebogamma , flebogamma dif, Gammagard liquid, Gammagard, gammagard s/d, iveegam, Gammaplex, Hizentra, Hyqvia, Octagam, Panzyga, Privigen, Qivigy, Xembify (discontinued: Carimune, carimune nf, panglobulin, sandoglobulin, Flebogamma , flebogamma dif, Gamimune, Gammagard, gammagard s/d, iveegam, Gammaplex, Gammar i.v.,gammar-p, Vivaglobin)
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Immune globulin (human)
Tradename
Proper name
Company
Number
Date
Products
Baygam, Gamastan S/DImmune Globulin (Human)GrifolsA-101134 RX1944-01-11
1 products
Immune globulin intravenous (human)
Tradename
Proper name
Company
Number
Date
Products
BivigamImmune Globulin Intravenous (Human)ADMA BiologicsA-125389 RX2012-12-19
2 products
GammaplexImmune Globulin Intravenous (Human)Bio Products LaboratoryA-125329 RX2017-02-06
3 products
Flebogamma 5%, Flebogamma 5% DifImmune Globulin Intravenous (Human)GrifolsA-125077 RX2003-12-15
3 products
OctagamImmune Globulin Intravenous (Human)OctapharmaA-125062 RX2004-05-21
9 products
PanzygaImmune Globulin Intravenous (Human)-ifasOctapharmaA-125587 RX2018-08-02
6 products
Gammagard, Gammagard S/D, IveegamImmune Globulin Intravenous (Human)TakedaA-103133 RX2000-07-27
2 products
Show 7 discontinued
Immune globulin infusion (human)
Tradename
Proper name
Company
Number
Date
Products
Gammagard LiquidImmune Globulin Infusion (Human)TakedaA-125105 RX2005-04-27
1 products
Immune globulin subcutaneous (human)
Tradename
Proper name
Company
Number
Date
Products
CutaquigImmune Globulin Subcutaneous (Human)-hippOctapharmaA-125668 RX2018-12-12
6 products
Show 1 discontinued
Immune globulin intravenous (human)
+
10% liquid
Tradename
Proper name
Company
Number
Date
Products
PrivigenImmune Globulin Intravenous (Human), 10% LiquidCSL BehringA-125201 RX2007-07-26
5 products
Immune globulin subcutaneous (human)
+
20% liquid
Tradename
Proper name
Company
Number
Date
Products
HizentraImmune Globulin Subcutaneous (Human), 20% LiquidCSL BehringA-125350 RX2010-03-04
5 products
Immune globulin infusion (human)
+
10% with recombinant human hyaluronidase
Tradename
Proper name
Company
Number
Date
Products
HyqviaImmune Globulin Infusion (Human), 10% with Recombinant Human HyaluronidaseTakedaA-125402 RX2014-09-12
1 products
Immune globulin intravenous
+
human
Tradename
Proper name
Company
Number
Date
Products
AscenivImmune Globulin Intravenous, Human-slraADMA BiologicsA-125590 RX2019-04-01
1 products
Immune globulin subcutaneous
+
human
Tradename
Proper name
Company
Number
Date
Products
Xembifyimmune globulin subcutaneous, human-klhwGrifolsA-125683 RX2019-07-03
4 products
Immune globulin intravenous
+
human-kthm
+
10% solution
Tradename
Proper name
Company
Number
Date
Products
QIVIGYImmune Globulin Intravenous, Human-kthm, 10% SolutionKedrionN-125822 RX2025-09-26
2 products
Labels
FDA
EMA
Brand Name
Status
Last Update
ascenivBiologic Licensing Application2025-05-06
babybigBiologic Licensing Application2024-12-05
bivigamBiologic Licensing Application2025-05-05
cnj-016Biologic Licensing Application2025-06-18
flebogammaBiologic Licensing Application2010-01-07
flebogamma difBiologic Licensing Application2006-11-01
gamastan s/dBiologic Licensing Application2010-10-28
gammagard liquidBiologic Licensing Application2011-07-22
gammaplexBiologic Licensing Application2010-06-24
gamunex-cBiologic Licensing Application2010-10-25
Show 11 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
4037 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Primary immunodeficiency diseasesD000081207————64111
Chronic inflammatory demyelinating polyradiculoneuropathyD020277EFO_1000868G61.81——3137
AgammaglobulinemiaD000361—D80.1——4116
Common variable immunodeficiencyD017074EFO_0000367D83——4116
Immunologic deficiency syndromesD007153—D84.9———3—3
Thrombocytopenic purpura idiopathicD016553EFO_0007160D69.3——11—2
Tropical spastic paraparesisD015493EFO_0007527G04.1———1—1
Chronic kidney failureD007676EFO_0003884N18.6———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hereditary angioedemasD054179EFO_0004131———3—14
AngioedemaD000799EFO_0005532T78.3——3——3
Igg deficiencyD017099—D80.3——3——3
Myasthenia gravisD009157EFO_0004991G70.0—11——2
PolyneuropathiesD011115EFO_0009562A69.22——1—12
Kidney transplantationD016030——111——2
PolyradiculoneuropathyD011129EFO_1001116———1——1
DermatomyositisD003882EFO_0000398M33——1——1
Central nervous system diseasesD002493—G96.9——1——1
Central nervous system infectionsD002494EFO_1001456A81——1——1
Show 7 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diffuse sclerodermaD045743EFO_0000404——2——13
BronchiectasisD001987—J4711———2
Diabetic nephropathiesD003928EFO_0000401——1———1
Kidney diseasesD007674EFO_0003086N08—1———1
Covid-19D000086382—U07.1—1———1
Coronavirus infectionsD018352EFO_0007224B34.2—1———1
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9—1———1
Soft tissue infectionsD018461———1———1
Necrotizing fasciitisD019115—M72.6—1———1
Fournier gangreneD018934—N49.3—1———1
Show 2 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FibrosisD005355——1————1
Healthy volunteers/patients———1————1
AsthmaD001249EFO_0000270J451————1
Ischemic strokeD000083242——1————1
StrokeD020521EFO_0000712I63.91————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
RabiesD011818—A82————11
Systemic sclerodermaD012595EFO_0000717M34————11
SclerosisD012598——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameHuman immunoglobulin g
INN_
Description
Immune globulin (human)
Classification
Unknown
Drug classantineoplastics (mitotic inhibitors; tubulin binders)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL IDCHEMBL1201599
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID66Y330CJHS (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
Panzyga – Pfizer
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
No data
Trends
No data
Safety
Black-box Warning
Black-box warning for: Asceniv, Bivigam, Cnj-016, Flebogamma, Gammagard liquid, Gammaplex, Gamunex-c, Privigen, Rhophylac
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
91,371 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use